SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: BigKahuna, BooDog, TOB, sox040713, Astavakra, TheHound
Search This Board:
Last Post: 10/25/2016 11:24:28 AM - Followers: 703 - Board type: Free - Posts Today: 22

Cellceutix Corporation (CTIX)
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
About Cellceutix: 

Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Cellceutix is now preparing its FDA application for a Phase 2 ovarian cancer study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is in a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of Oral Mucositis in patients with head and neck cancer. Brilacidin-OM, a defensin mimetic compound, has shown in an animal model to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol completed a Phase 2 trial. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria (Superbugs). Brilacidin is also being evaluated in a Phase 2 Proof-of-Concept trial as a novel treatment for Ulcerative Proctitis. Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available on the Cellceutix web site at 


Ongoing Human Trials:
Product Pipeline:


Upcoming Milestones:

Recent News and Press Releases:

Seeking Alpha focus articles on CTIX:

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

SEC Filings (CIK:0001355250):

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:



Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet

Investor Relations:

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Current Report Filing (8-k) 09/15/2016 08:01:38 AM
CTIX News: Current Report Filing (8-k) 09/13/2016 08:01:27 AM
CTIX News: Annual Report (10-k) 09/13/2016 06:04:52 AM
CTIX News: Insider Financial Publishes New Research On Three Promising Biotechs 07/16/2016 08:00:00 AM
CTIX News: Securities Registration: Employee Benefit Plan (s-8) 07/15/2016 04:52:11 PM
#161285  Sticky Note $CTIX Upcoming Milestones and Pipeline: KarinCA 10/12/16 08:48:35 PM
#161171  Sticky Note B-UP Due Diligence sox040713 10/10/16 07:21:01 PM
#161105  Sticky Note NEWS--Cellceutix Phase 2 Trial Initial Data Shows Potential BigKahuna 10/10/16 10:22:18 AM
#158037  Sticky Note 9-1-16 New Cellceutix Report Out. Worth a read imo. TheHound 09/01/16 08:36:02 AM
#156603  Sticky Note CTIX Interviews, Potential Catalysts and Past Milestones sox040713 08/11/16 06:13:05 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#162174   It is likely to end with capitulating high TheMonolith 10/25/16 11:24:28 AM
#162173   Recent Company Update ----> TheHound 10/25/16 11:16:38 AM
#162172   Appreciate the suggestions, but I think it's more TheHound 10/25/16 11:15:31 AM
#162171   Someone's getting hangry for some shares. See the BooDog 10/25/16 11:05:03 AM
#162170   We got them right where we want 'em! scottsmith 10/25/16 10:37:12 AM
#162169   Then put it here: iclight 10/25/16 09:30:46 AM
#162167   current news dude. ongoing in fact. TheHound 10/25/16 09:10:24 AM
#162166   Old news dude tombrady12nh 10/25/16 09:06:06 AM
#162165   Right on schedule! Detonate 10/25/16 09:05:40 AM
#162164   biotech is a very volatile, risky investment and TheHound 10/25/16 08:54:59 AM
#162163   Where the heck are my Ruby Slippers? TheDane 10/25/16 08:41:58 AM
#162162   and yet we keep going down. the MXAMDUD 10/25/16 08:39:05 AM
#162161   B-UP Due Diligence TheHound 10/25/16 08:25:27 AM
#162160   Lawsuit against $CTIX Shit-canned. Sanctions against Rosen Law TheHound 10/25/16 08:20:45 AM
#162159   $CTIX recent hires: TheHound 10/25/16 08:18:49 AM
#162158   Recent Company Update ----> TheHound 10/25/16 08:17:49 AM
#162157   Prurisol (Ph2b) has the potential to be the TheHound 10/25/16 08:16:40 AM
#162156   Brilacidin – A Winner in the Making with TheHound 10/25/16 08:13:43 AM
#162155   Quote: Kevetrin is a novel drug candidate targeting p53 TheHound 10/25/16 08:11:42 AM
#162154   So what are you saying, that one company TheBunny 10/25/16 01:54:56 AM
#162153   Since we are feeling nostalgic, do you know sox040713 10/25/16 01:16:47 AM
#162152   Beaten-down biotech shares could see a monster relief profstok 10/24/16 11:58:39 PM
#162150   CTIX wasn't affected by the sector (to the tombrady12nh 10/24/16 10:16:10 PM
#162149   One needs to look at the biotech indexes JSN2000 10/24/16 09:20:09 PM
#162146   "4, Shareholder meeting due in December." additional info: loanranger 10/24/16 06:58:22 PM
#162145   Jtorrence It is possible even if J&J add to Echo20 10/24/16 06:32:34 PM
#162144   "The seller is the company otherwise there would loanranger 10/24/16 06:24:45 PM
#162143   Don't you think that's stretching it a bit. JTORENCE 10/24/16 06:06:22 PM
#162142   Thanks Daubers...excellent Post. I believe there are multiple wild4ctix 10/24/16 05:54:23 PM
#162141   This company has a very powerful pipeline 58nout 10/24/16 05:52:41 PM
#162140   FINRA short sales of CTIX AlanC 10/24/16 05:38:10 PM
#162139   Thanks for sharing! At the end of the sox040713 10/24/16 05:25:40 PM
#162138   thanks! I believe this! JUST 10-11-12 10/24/16 04:44:11 PM
#162137   prob nothing bad....just nothing, for many months To infinity and beyond! 10/24/16 04:35:05 PM
#162135   Thank you Daubs for that post! keltoi 10/24/16 03:57:28 PM
#162134   Agree. Very powerful pipeline indeed. And some BooDog 10/24/16 03:50:16 PM
#162133   Hope your right but this stock has come luxe 10/24/16 03:48:57 PM
#162132   4th Quarter of 2017 starts in about 11 scottsmith 10/24/16 03:44:03 PM
#162131   Why be so cryptic? Who did you scottsmith 10/24/16 03:40:31 PM
#162130   First off...we are talking about a nickel here DaubersUP 10/24/16 03:38:46 PM
#162129   I have an idea... scottsmith 10/24/16 03:34:41 PM
#162128   SS when does the 4th Q start? Lol tombrady12nh 10/24/16 03:33:01 PM
#162127   Cheapies again lol tombrady12nh 10/24/16 03:31:42 PM
#162124   That 43K share offer was a fraud!!! Don't luxe 10/24/16 03:01:01 PM
#162123   Thanks. Again, I don't generally disagree. I Need Help 10/24/16 02:54:03 PM
#162122   That is where it looks like it going. luxe 10/24/16 02:52:59 PM
#162121   "one reason why not to put all ones cybermich 10/24/16 02:50:37 PM
#162120   Funny thing with many small cap biotechs, some I Need Help 10/24/16 02:47:45 PM
#162119   i may lower my bid from 1.05 to scottsmith 10/24/16 02:40:54 PM
#162118   I don't disagree. I Need Help 10/24/16 02:37:08 PM